Skip to content
10-Q

Quarterly Report

BioNexus Gene Lab Corp. BGLC

0001477932-25-008343

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 1.8M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.8M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.78M sh
Capex Q3 2025 · Sep 30, 2025 $35.99K
Capex Q3 2025 · Sep 30, 2024 $222.97K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$2.8M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$2.31M
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.82M
Stockholders Equity Q3 2025 · Jun 30, 2025 $7.52M
Stockholders Equity Q3 2025 · Mar 31, 2025 $7.77M
Stockholders Equity Q3 2025 · Dec 31, 2024 $8.32M
Stockholders Equity Q3 2025 · Sep 30, 2024 $9.39M
Stockholders Equity Q3 2025 · Jun 30, 2024 $9.55M
Stockholders Equity Q3 2025 · Mar 31, 2024 $9.34M
Stockholders Equity Q3 2025 · Dec 31, 2023 $9.66M
Current Liabilities Q3 2025 · Sep 30, 2025 $678.02K
Current Liabilities Q3 2025 · Dec 31, 2024 $1.95M
Total Liabilities Q3 2025 · Sep 30, 2025 $804.97K
Total Liabilities Q3 2025 · Dec 31, 2024 $2.11M
Current Assets Q3 2025 · Sep 30, 2025 $5.63M
Current Assets Q3 2025 · Dec 31, 2024 $7.43M
Total Assets Q3 2025 · Sep 30, 2025 $7.62M
Total Assets Q3 2025 · Dec 31, 2024 $10.43M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.40
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.09
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.75
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.70
Sga Expense Q3 2025 · Sep 30, 2025 $445.69K
Sga Expense Q3 2025 · Sep 30, 2025 $1.35M
Sga Expense restated Q3 2025 · Sep 30, 2024 $792.41K
Sga Expense restated Q3 2025 · Sep 30, 2024 $1.67M
Rd Expense Q3 2025 · Sep 30, 2025 $14.88K
Rd Expense Q3 2025 · Sep 30, 2025 $39.57K
Rd Expense Q3 2025 · Sep 30, 2024 $10.44K
Rd Expense Q3 2025 · Sep 30, 2024 $30.12K
Net Income Q3 2025 · Sep 30, 2025 −$708.99K
Net Income Q3 2025 · Sep 30, 2025 −$1.95M
Net Income Q3 2025 · Sep 30, 2024 −$1.35M
Net Income Q3 2025 · Sep 30, 2024 −$1.25M
Operating Income Q3 2025 · Sep 30, 2025 −$702.51K
Operating Income Q3 2025 · Sep 30, 2025 −$1.93M
Operating Income Q3 2025 · Sep 30, 2024 −$1.34M
Operating Income Q3 2025 · Sep 30, 2024 −$1.16M
Gross Profit Q3 2025 · Sep 30, 2025 $377.69K
Gross Profit Q3 2025 · Sep 30, 2025 $1.09M
Gross Profit Q3 2025 · Sep 30, 2024 $326.54K
Gross Profit Q3 2025 · Sep 30, 2024 $980.29K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.17M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $5.85M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $2.3M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $6.01M
Revenue Q3 2025 · Sep 30, 2025 $2.54M
Revenue Q3 2025 · Sep 30, 2025 $6.94M
Revenue Q3 2025 · Sep 30, 2024 $2.63M
Revenue Q3 2025 · Sep 30, 2024 $6.99M